137 related articles for article (PubMed ID: 2972593)
1. Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity.
Smokovitis A; Kokolis N; Alexaki-Tzivanidou E
Haemostasis; 1988; 18(3):146-53. PubMed ID: 2972593
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of plasminogen activator activity in the intima and media of the normal human aorta and other large arteries: immunological identification of the plasminogen activator(s).
Smokovitis AA; Kokolis NA; Alexaki E; Binder BR
Thromb Res; 1989 Jul; 55(2):259-65. PubMed ID: 2528844
[TBL] [Abstract][Full Text] [Related]
3. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
4. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
[TBL] [Abstract][Full Text] [Related]
5. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
Booth NA; Anderson JA; Bennett B
Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
7. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
8. Circadian variations of plasminogen activator activity, tissue-type plasminogen activator antigen, plasminogen activator inhibition and plasmin inhibition in rat aorta, heart and brain are influenced by endotoxin or aspirin or endotoxin plus aspirin.
Kokolis N; Rekkas C; Tsandarliotou M; Smokovitis A
Haemostasis; 1995; 25(3):106-13. PubMed ID: 7607578
[TBL] [Abstract][Full Text] [Related]
9. Properties of a partially purified preparation of a circulating plasminogen activator.
Ogston D; Bennett B; Mackie M
Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
[No Abstract] [Full Text] [Related]
10. Circadian variation of plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition in aorta, heart, brain and lungs of the rat. Sex-related differences.
Smokovitis A; Kokolis N; Tsandarliotou M
Thromb Res; 1993 Mar; 69(5):425-33. PubMed ID: 8497858
[TBL] [Abstract][Full Text] [Related]
11. The influence of the polyphenols of cider on plasmin and plasminogen activators.
Ogston D; Lea AG; Langhorne P; Wilson SB
Br J Haematol; 1985 Aug; 60(4):705-13. PubMed ID: 3161536
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of plasminogen activators to suicide inactivation.
Mor A; Reboud-Ravaux M; Mazaleyrat JP; Wakselman M
Thromb Res Suppl; 1988; 8():35-44. PubMed ID: 3144767
[TBL] [Abstract][Full Text] [Related]
13. Some fibrinolytic properties of the human arteries and veins walls.
Donner L; Vodáková L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):451-9. PubMed ID: 2431965
[TBL] [Abstract][Full Text] [Related]
14. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.
Reilly JM; Sicard GA; Lucore CL
J Vasc Surg; 1994 May; 19(5):865-72. PubMed ID: 8170041
[TBL] [Abstract][Full Text] [Related]
16. Regions of constantly increased plasminogen activator activity along the intima of the normal aorta.
Smokovitis A
Haemostasis; 1978; 7(5):303-19. PubMed ID: 151002
[TBL] [Abstract][Full Text] [Related]
17. Great variation in the response of tissue plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition to endotoxin, aspirin and endotoxin after administration of aspirin.
Smokovitis A; Kokolis N; Ploumis T
Thromb Res; 1988 May; 50(4):495-505. PubMed ID: 2970689
[TBL] [Abstract][Full Text] [Related]
18. Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma.
Schönermark MP; Issing PR; Erbrich BK; Lenarz T
Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):245-52. PubMed ID: 10086616
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
20. Effect of orchidectomy on tissue plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition.
Kokolis NA
Haemostasis; 1990; 20(4):233-40. PubMed ID: 2147015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
